Write in a clean editor, then format for The Lancet Healthy Longevity in one click — DocuGuru applies the official Clinical & Medical Journals template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
The Lancet Healthy Longevity is a peer-reviewed journal published by Clinical & Medical Journals, covering Frailty in Older Adults, Dementia and Cognitive Impairment Research, Health Systems, Economic Evaluations, Quality of Life. Over its lifetime it has published 852 papers, which have received 20,956 citations.
| Publisher | Clinical & Medical Journals |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. The Lancet Healthy Longevity. 2023;12(3):45–58.
Formats any DOI in The Lancet Healthy Longevity style. No sign-up. |
| Publishes research in | Frailty in Older Adults Dementia and Cognitive Impairment Research Health Systems, Economic Evaluations, Quality of Life Chronic Disease Management Strategies Health disparities and outcomes |
| ISSN | 2666-7568 |
| Citation impact (2-yr) | 10.81 |
| h-index | 78 |
| i10-index | 361 |
| Article processing charge | $5,000 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | University College London |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
BACKGROUND: Bone fractures are a global public health issue; however, to date, no comprehensive study of their incidence and burden has been done. We aimed to measure the global, regional, and national incidence, prevalence, and years lived with disability (YLDs) of fractures from 1990 to 2019. METHODS: Using the framework of the Global Burden of…
BackgroundThe triglyceride glucose (TyG) index is an easily accessible surrogate marker of insulin resistance, an important pathway in the development of type 2 diabetes and cardiovascular diseases. However, the association of the TyG index with cardiovascular diseases and mortality has mainly been investigated in Asia, with few data available from other regions of the world.…
BACKGROUND: Randomised controlled trials (RCTs) inform prescription guidelines, but stringent eligibility criteria exclude individuals with vulnerable characteristics, which we define as comorbidities, concomitant medication use, and vulnerabilities due to age. Poor external validity can result in inadequate treatment decision information. Our first aim was to quantify the extent of exclusion of individuals with vulnerable characteristics…
BACKGROUND: Approximately 80% of the 463 million adults worldwide with diabetes live in low- and middle-income countries (LMICs). A major obstacle to designing evidence-based policies to improve diabetes outcomes in LMICs is the limited nationally representative data on the current patterns of treatment coverage. The objectives of this study are (1) to estimate the proportion…
BACKGROUND: Benign prostatic hyperplasia is a common urological disease affecting older men worldwide, but comprehensive data about the global, regional, and national burden of benign prostatic hyperplasia and its trends over time are scarce. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, we estimated global trends in, and…
